Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Facebook
Tweet
Print
Francisco De La Cruz, PharmD, RPh
Pharmacist
St Peter's Health Partners
Poster(s):
(11-430) Impact of Dalbavancin Use as a First-line Intravenous Antibiotic in Refractory Cellulitis on Hospital Admissions and Cost
Wednesday, December 10, 2025
12:30 PM - 1:30 PM